NASDAQ:DXCM Lawsuit ALERT: Investors Who Lost Money With Shares of DexCom, Inc. (NASDAQ:DXCM) Should Contact the Shareholders Foundation
![mail@shareholdersfoundation.com](https://cdn.nwe.io/files/x/69/1d/49135fc2385c07729ec798d2078c.jpg)
SAN DIEGO, August 28, 2024 (Newswire.com) - A lawsuit was filed for certain investors in DexCom, Inc. (NASDAQ:DXCM) shares. Investors in NASDAQ:DXCM shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554
The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in DexCom, Inc. (NASDAQ:DXCM) shares.
![mail@shareholdersfoundation.com](https://www.accesswire.com/imagelibrary/2a31cda0-11fb-4afb-b93f-2e6a6f8a2a58/908833/526160fd264c42e23ab2d1a54f48.jpg)
Shareholders Foundation - mail@shareholdersfoundation.com or +1(858) 779 - 1554
Investors that purchased shares of DexCom, Inc. (NASDAQ:DXCM) have certain options and for certain investors are short and strict deadlines running. Deadline: October 21, 2024. NASDAQ:DXCM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On July 25, 2024, after the closure of market trading, DexCom, Inc. announced its financial results for the second quarter of 2024. The Company reported revenue figures amounting to $1.004 billion. However, the press release conveyed that the Company's performance did not meet its established high standards of execution. Furthermore, DexCom revised its revenue guidance for the full fiscal year of 2024, projecting a revenue range between $4 billion and $4.05 billion. This adjustment was attributed to "certain unique items impacting 2024 seasonality," which have been identified as factors influencing the Company's financial outlook.
On August 21, 2024, a lawsuit was filed by an investor in NASDAQ:DXCM shares against DexCom, Inc. over alleged securities laws violations. The plaintiff alleged that the defendants failed to disclose the true state of DexCom's salesforce, that DexCom, Inc was not truly equipped to execute on the Company's perceived growth potential, and that as a result of their purchases of DexCom's common stock between January 8, 2024 to July 25, 2024, investors suffered economic loss.
Those who purchased DexCom, Inc. (NASDAQ:DXCM) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact Information
Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554
SOURCE: Shareholders Foundation, Inc.
Source: Shareholders Foundation, Inc.